India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Image

India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • ID: 4342727
  • Report
  • Region: India
  • 143 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • Hospira Inc
  • Merck & Co Inc
  • MORE
India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

The new report, "India Drug Delivery Devices Market Outlook to 2023", provides key market data on the India Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the India Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • Hospira Inc
  • Merck & Co Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Drug Delivery Devices Market, India
3.1 Drug Delivery Devices Market, India, Revenue ($m), 2009-2023
3.2 Drug Delivery Devices Market, India, Revenue Mix ($m), 2016
3.3 Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016
3.4 Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023
3.5 Drug Delivery Devices Market, India, Revenue ($m), 2009-2016
3.6 Drug Delivery Devices Market, India, Revenue ($m), 2016-2023
3.7 Drug Delivery Devices Market, India, Volume (Units), 2009-2023
3.8 Drug Delivery Devices Market, India, Volume (Units), 2009-2016
3.9 Drug Delivery Devices Market, India, Volume (Units), 2016-2023
3.10 Drug Delivery Devices Market, India, Company Share by Revenue ($m), 2016
4 Central Venous Catheters Market, India
4.1 Central Venous Catheters Market, India, Revenue Mix ($m), 2016
4.2 Central Venous Catheters Market, India, Segment Contribution (%), 2016
4.3 Central Venous Catheters Market, India, Revenue ($m), 2009-2016
4.4 Central Venous Catheters Market, India, Revenue ($m), 2016-2023
4.5 Central Venous Catheters Market, India, Volume (Units), 2009-2016
4.6 Central Venous Catheters Market, India, Volume (Units), 2016-2023
4.7 Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2015-2016
4.8 Central Venous Catheters Market, India, Company Share by Revenue ($m), 2016
5 Infusion Systems Market, India
5.1 Infusion Systems Market, India, Revenue Mix ($m), 2016
5.2 Infusion Systems Market, India, Segment Contribution (%), 2016
5.3 Infusion Systems Market, India, Revenue ($m), 2009-2016
5.4 Infusion Systems Market, India, Revenue ($m), 2016-2023
5.4.1 Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2009-2016
5.4.2 Syringe Pumps Market, India, Revenue ($m), by Segment, 2009-2016
5.4.3 Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2016-2023
5.4.4 Syringe Pumps Market, India, Revenue ($m), by Segment, 2016-2023
5.5 Infusion Systems Market, India, Volume (Units), 2009-2016
5.6 Infusion Systems Market, India, Volume (Units), 2016-2023
5.6.1 Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2009-2016
5.6.2 Syringe Pumps Market, India, Volume (Units), by Segment, 2009-2016
5.6.3 Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2016-2023
5.6.4 Syringe Pumps Market, India, Volume (Units), by Segment, 2016-2023
5.7 Infusion Systems Market, India, Distribution Share by Revenue ($m), 2015-2016
5.8 Infusion Systems Market, India, Company Share by Revenue ($m), 2016
6 Needle Free Injections Market, India
6.1 Needle Free Injections Market, India, Revenue ($m), 2009-2016
6.2 Needle Free Injections Market, India, Revenue ($m), 2016-2023
6.3 Needle Free Injections Market, India, Volume (Units), 2009-2016
6.4 Needle Free Injections Market, India, Volume (Units), 2016-2023
6.5 Needle Free Injections Market, India, Distribution Share by Revenue ($m), 2015-2016
6.6 Needle Free Injections Market, India, Company Share by Revenue ($m), 2016
7 Metered Dose Inhaler Devices Market, India
7.1 Metered Dose Inhaler Devices Market, India, Revenue ($m), 2009-2016
7.2 Metered Dose Inhaler Devices Market, India, Revenue ($m), 2016-2023
7.3 Metered Dose Inhaler Devices Market, India, Volume (Units), 2009-2016
7.4 Metered Dose Inhaler Devices Market, India, Volume (Units), 2016-2023
7.5 Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), 2015-2016
7.6 Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), 2016
8 Overview of Key Companies in India, Drug Delivery Devices Market
8.1 Teleflex Inc
8.1.1 Company Overview
8.2 GlaxoSmithKline Plc
8.2.1 Company Overview
8.3 B. Braun Melsungen AG
8.3.1 Company Overview
8.4 Baxter International Inc
8.4.1 Company Overview
8.5 AstraZeneca Plc
8.5.1 Company Overview
8.6 Boehringer Ingelheim GmbH
8.6.1 Company Overview
8.7 Fresenius Kabi AG
8.7.1 Company Overview
8.8 Pfizer Inc
8.8.1 Company Overview
8.9 Smiths Medical
8.9.1 Company Overview
8.10 Merck & Co Inc
8.10.1 Company Overview
8.11 Cipla Ltd
8.11.1 Company Overview
8.12 Hospira Inc
8.12.1 Company Overview
8.12 Terumo Corp
8.12.1 Company Overview
8.19 Becton Dickinson and Co
8.19.1 Company Overview
8.13 Medtronic Plc
8.13.1 Company Overview
8.14 Nipro Corp
8.14.1 Company Overview
9 Drug Delivery Devices Market Pipeline Products
10 Financial Deals Landscape
10.1 Acquisition
10.1.1 Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs
10.2 Asset Transactions
10.2.1 Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter
10.2.2 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
10.3 Equity Offerings
10.3.1 Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities
10.4 Partnerships
10.4.1 Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma
10.4.2 PharmaJet Enters into Agreement with Serum Institute of India
10.4.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
10.4.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
10.4.5 Eris Lifesciences Enters into Distribution Agreement with India Medtronic
10.4.6 Pfizer Terminates its Licensing Agreement with pSivida
10.4.7 Bayer Enters into Licensing Agreement with DelSiTech
10.4.8 BioCorRx Enters into Licensing Agreement with Therakine
11 Recent Developments
11.1 Corporate Communications
11.1.1 Jul 12, 2017: Sun Pharmaceutical Industries Announces Appointment of Mr. Kalyansundaram Subramanian as the Director
11.1.2 Jun 09, 2017: Poly Medicure announces appointment of Chief Operating Officer
11.1.3 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
11.1.4 Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer
11.1.5 Feb 08, 2017: Cipla Updates Appoints Mr. Mital Sanghvi To Senior Business Finance Role
11.1.6 Jan 09, 2017: Cipla appoints Peter Lankau as an Independent Director on its Board
11.1.7 Nov 29, 2016: Cipla appoints Ireena Vittal as an Independent Director on its Board
11.1.8 Nov 10, 2016: Morepen Labs: Appoints Additional Director
11.1.9 Aug 12, 2016: Cipla Names Umang Vohra as MD & Global CEO; Samina Vaziralliis Executive Vice-Chairman
11.1.10 Aug 01, 2016: Cipla appoints Kedar Upadhye as Global Chief Financial Officer
11.2 Financial Announcements
11.2.1 May 26, 2017: Sun Pharma reports Q4 & FY17 results
11.2.2 May 25, 2017: Cipla announces Q4 & FY 17 results Continued strong performance across key markets
11.2.3 May 12, 2017: Dr. Reddy’s Q4 and FY17 Financial Results
11.2.4 Feb 14, 2017: Sun Pharma reports Q3FY17 results
11.2.5 Feb 08, 2017: Morepen labs reports yet another growth-filled quarter
11.2.6 Feb 04, 2017: Dr. Reddy’s Q3 and 9M FY17 Financial Results
11.2.7 Nov 15, 2016: Oncocyte Announces Publication Of Breast Cancer Diagnostic Test Abstract; Poster To Be Presented At The San Antonio Breast Cancer Symposium On December 9, 2016
11.2.8 Nov 14, 2016: Medtronic Receives FDA Approval for Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator
11.2.9 Nov 14, 2016: With Health Canada approval, Dexcom G5 Mobile CGM System is the First and Only Medical Device in North America for Making Daily Diabetes Decisions Without Painful Fingersticks
11.2.10 Nov 11, 2016: CHMP Adopts Positive Opinion to include Self-Administration for RUCONEST
11.2.11 Nov 09, 2016: Cipla announces Q2 FY17 results - Improved profitability in base business & Strengthened R&D pipeline
11.2.12 Nov 09, 2016: Morepen Labs reports 118 pct jump in net profits for the Q2 of FY 2016-17
11.2.13 Oct 25, 2016: Dr. Reddy’s Q2 and H1 FY17 Financial Results
11.2.14 Aug 12, 2016: Sun Pharma reports Q1FY17 results
11.2.15 Aug 12, 2016: Sun Pharmaceutical Industries announces Unaudited results for the Quarter ended 30 th June, 2016
11.2.16 Aug 12, 2016: Cipla announces Q1 FY 17 Results Performance reflects continued momentum in key markets and improvement in base EBITDA margins
11.2.17 Aug 01, 2016: Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016
11.2.18 Jul 26, 2016: Dr. Reddy’s Q1 FY17 Financial Results
11.3 Legal And Regulatory
11.3.1 Jun 16, 2017: Dr. Reddy's Laboratories: Update on USFDA Audit
11.3.2 Jun 14, 2017: Dr. Reddy's Provides Update on API manufacturing plant at Miryalaguda
11.3.3 Jun 01, 2017: Successful AAALAC accreditation for Envigo facilities in Hyderabad, India
11.3.4 May 29, 2017: Phosphagenic - Mylan Arbitration Update - expert report on quantum of damages claimed filed
11.3.5 May 25, 2017: Dr. Reddy's Laboratories Provides Update on Srikakulum Plant
11.3.6 Apr 14, 2017: Dr. Reddy’s Provides Update on USFDA Audit
11.3.7 Apr 03, 2017: Dr. Reddy's Laboratories Provides Update on USFDA Inspection at Srikakulam plant
11.3.8 Mar 14, 2017: Sun Pharma Provides Update on Mohali Facility
11.3.9 Mar 14, 2017: Sun Pharmaceutical Industries Provides Update on Mohali Facility
11.3.10 Feb 21, 2017: Dr. Reddy's Laboratories Announces US FDA Inspection on Miryalaguda Facility
11.3.11 Dec 13, 2016: TUV Certification for the Bengaluru Facility
11.3.12 Dec 08, 2016: Sun Pharma Provide Update on USFDA Inspection for Halol facility
11.3.13 Sep 30, 2016: Clarification sought from Cipla
11.4 Other Significant Developments
11.4.1 Feb 08, 2017: Dr. Reddy's Expands Commercial Operations in Europe
11.4.2 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System
11.5 Product News
11.5.1 May 22, 2017: Aptar Pharma to Highlight Drug Delivery Systems Portfolio at FCE Brazil
11.6 Strategy And Business Planning
11.6.1 Dec 01, 2016: Aptar Pharma Nears Completion Of Elastomer Component Capacity In North America
11.6.2 Oct 07, 2016: Leading global pharmaceutical company, Dr. Reddy’s Laboratories now in Colombia
11.6.3 Sep 28, 2016: Piramal plans to expand its API development & manufacturing capabilities at Digwal plant
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Company Share Analysis
12.1.5 Distribution Share Analysis
12.1.6 Benchmarking
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023
Table 2: Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016
Table 3: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023
Table 4: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Drug Delivery Devices Market, India, Volume (Units), 2009-2023
Table 7: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016
Table 8: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023
Table 9: Drug Delivery Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016
Table 10: Central Venous Catheters Market, India, Segment Contribution (%), 2016
Table 11: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016
Table 14: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023
Table 15: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Infusion Systems Market, India, Segment Contribution (%), 2016
Table 18: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 20: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Table 21: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Table 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 24: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016
Table 25: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023
Table 26: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016
Table 27: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016
Table 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023
Table 29: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023
Table 30: Infusion Systems Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Infusion Systems Market, India, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016
Table 35: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023
Table 36: Needle Free Injections Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 37: Needle Free Injections Market, India, Company Share by Revenue ($m), USD Constant, 2016
Table 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016
Table 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023
Table 42: Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Drug Delivery Devices Market Pipeline Products
Table 45: Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs
Table 46: Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter
Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
Table 48: Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities
Table 49: Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma
Table 50: PharmaJet Enters into Agreement with Serum Institute of India
Table 51: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
Table 52: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Table 53: Eris Lifesciences Enters into Distribution Agreement with India Medtronic
Table 54: Pfizer Terminates its Licensing Agreement with pSivida
Table 55: Bayer Enters into Licensing Agreement with DelSiTech
Table 56: BioCorRx Enters into Licensing Agreement with Therakine

List of Figures
Figure 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023
Figure 2: Drug Delivery Devices Market, India, Revenue Mix ($m), 2016
Figure 3: Drug Delivery Devices Market, India, Category Contribution (%), 2016
Figure 4: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023
Figure 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Drug Delivery Devices Market, India, Volume (Units), 2009-2023
Figure 8: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016
Figure 9: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023
Figure 10: Drug Delivery Devices Market, India, Company Share (%) 2016
Figure 11: Central Venous Catheters Market, India, Revenue Mix ($m), 2016
Figure 12: Central Venous Catheters Market, India, Segment Contribution (%), 2016
Figure 13: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016
Figure 16: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023
Figure 17: Central Venous Catheters Market, India, Company Share (%) 2016
Figure 18: Infusion Systems Market, India, Revenue Mix ($m), 2016
Figure 19: Infusion Systems Market, India, Segment Contribution (%), 2016
Figure 20: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016
Figure 27: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023
Figure 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016
Figure 29: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016
Figure 30: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023
Figure 31: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023
Figure 32: Infusion Systems Market, India, Company Share (%) 2016
Figure 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016
Figure 36: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023
Figure 37: Needle Free Injections Market, India, Company Share (%) 2016
Figure 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016
Figure 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023
Figure 42: Metered Dose Inhaler Devices Market, India, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Teleflex Inc
  • GlaxoSmithKline Plc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • Pfizer Inc
  • Smiths Medical
  • Merck & Co Inc
  • Cipla Ltd
  • Hospira Inc
  • Terumo Corp
  • Becton Dickinson and Co
  • Medtronic Plc
  • Nipro Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll